Quantum DFT studies on the drug delivery of favipiravir using pristine and functionalized chitosan nanoparticles
Sheyda Ataei, Ebrahim Nemati-Kande, Aidin Bahrami · 2023
Read Quantum DFT studies on the drug delivery of favipiravir using pristine and functionalized chitosan nanoparticles by Sheyda Ataei, Ebrahim Nemati-Kande, Aidin Bahrami (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10713654.txt.
Description
Sheyda Ataei, Ebrahim Nemati-Kande, and Aidin Bahrami test chitosan nanoparticles as carriers for an antiviral drug in a 2023 computer study. The drug is favipiravir, used against COVID-19, and the carrier is made from chitosan, a body-friendly material drawn from natural sources. Better delivery could cut side effects and dose sizes.
Using quantum chemistry methods in a simulated water setting, the team measured how the drug sticks to plain chitosan and to four altered forms. Binding ran through hydrogen bonds, and plain chitosan held the drug most strongly. Altered forms bound more weakly, which can help release. Since grip and release can be tuned by acidity and salt, the authors offer their numbers as a design guide.
Catalog record
| CREATOR | Sheyda Ataei, Ebrahim Nemati-Kande, Aidin Bahrami |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 43 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |